Tumor suppressor genes (TSGs) such as CDKN2A and TP53 are involved in early stages of HNSCC,91 while PTEN is implicated in later stages, rather than oncogene mutation. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.